Eli Lilly and Company (NYSE:LLY) is one of the most profitable growth stocks to buy according to billionaires. On August 1, ...

The number of people taking weight-loss injections is exploding. With more and more men going “on the needle”, here’s what ...

A new study shows that weight loss medication patients can experience hunger, eat well-balanced meals, and still make ...

As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

INFLUENCER and YouTube star Tana Mongeau has issued a dramatic warning to fans after trying the weight loss jab Mounjaro. The ...

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

Topline results from the SURPASS-CVOT trial show that once-weekly tirzepatide has a cardiovascular risk profile similar to ...

A hormone expert has explained why some people’s sex drive goes ‘through the roof’ while using Mounjaro. Use of the drug for ...

Diabetes drug Mounjaro helped people lose 16% of weight, study finds Two trials have now found tirzepatide, sold under the brand name Mounjaro as a diabetes treatment, to be effective for weight loss.

Both Ozempic, or semaglutide, and Mounjaro, or tirzepatide, mimic the effects of the gut hormone GLP-1, which stimulates the body's production of insulin and slows the passage of food through the ...

Mounjaro patients were also 2.6 times more likely to achieve 10% weight loss and 1.8 times more likely to lose 5% of their weight, according to Truveta, which was earlier reported on by CNBC.